[PDF] Top 20 Comunicación para la Paz: una propuesta pedagógica para el Cambio Social
Has 10000 "Comunicación para la Paz: una propuesta pedagógica para el Cambio Social" found on our website. Below are the top 20 most common "Comunicación para la Paz: una propuesta pedagógica para el Cambio Social".
Evaluation of the effectiveness and safety of glucocorticoids intravitreal implant therapy in macular edema due to retinal vein occlusion
... the intravitreal therapy, all patients underwent ophthalmic examination, which embraced: 1) BCVA using the Snellen visual acuity chart under identical testing con- ditions; 2) slit lamp examination ... See full document
23
Retinal vein occlusion and macular edema – critical evaluation of the clinical value of ranibizumab
... to safety and efficacy is fraught with com- plication. In addition, safety and efficacy alone may not be the only ...of therapy, cost, phakic status, ease of treatment, and comorbid ocular and ... See full document
8
Comparison of safety and efficacy of single dose intravitreal injection of triamcinolone acetonide 1 0 mg versus dexamethasone 0 7 mg intravitreal implant in patients with macular edema due to retinal vein occlusion
... dexamethasone intravitreal implant. The Global Evaluation of Implantable dExamethasone in Retinal Vein Occlusion with Macular Edema (GENEVA) Trials were two Phase ... See full document
109
Intravitreal bevacizumab for macular edema due to branch retinal vein occlusion: 12-month results
... of intravitreal triamcinolone injection(s) or grid laser photocoagulation therapy, or ischemic BRVO were excluded from this ...mologic evaluation at baseline, day 1, day 7, month 1, and at monthly ... See full document
30
Role of Ranibizumab in macular edema due to branch retinal vein occlusion
... after intravitreal bevacizumab (Avastin) in eyes with persistent macular oedema secondary to branch retinal vein occlusion (BRVO) or central retinal vein occlusion ... See full document
Intravitreal Pharmacotherapy for the Treatment of Macular Edema Secondary to Branch Retinal Vein Occlusion: A Narrative Review
... clinical evaluation in groups 1 and 3. Only one dexamethasone implant was injected in patients in group ...central macular thickness did not differ between the 3 groups, but at the 6-month follow-up, ... See full document
21
Intravitreal bevacizumab injections versus dexamethasone implant for treatment-naïve retinal vein occlusion related macular edema
... DEX implant as a primary treatment for RVO is justified for patients in whom there is a reason to minimize the number of treatment and follow-up ...DEX implant may have stronger positive effect to either ... See full document
6
Critical appraisal of the clinical utility of the dexamethasone intravitreal implant (Ozurdex<sup>®</sup>) for the treatment of macular edema related to branch retinal vein occlusion or central retinal vein occlusion
... DEX implant is an additional phar- macologic agent in our ...branch retinal vein occlusions associated with macular edema and significant hemorrhage, who are unwilling or unable to ... See full document
18
Intravitreal dexamethasone implant for central retinal vein occlusion without macular edema
... central retinal veins (CRV), pres- ence of retinal hemorrhage, and cotton wool ...1). Retinal hemorrhage was subjectively graded as 0 = no hemor- rhages, 1 = minimal/small hemorrhages, 2 = medium ... See full document
12
Post-marketing surveillance study of the safety of dexamethasone intravitreal implant in patients with retinal vein occlusion or noninfectious posterior segment uveitis
... DEX safety in patients who receive more than two injections, as no patients received more than two injec- tions in the global registration studies of DEX for treatment of RVO-associated macular edema ... See full document
5
Intravitreal dexamethasone implant versus triamcinolone acetonide for macular oedema of central retinal vein occlusion: quantifying efficacy and safety
... and safety of intravitreal triamcinolone and dexa- methasone implant over a study period of 6 ...months. Intravitreal desamethasone group [IVD group (n = 20)] received ...dexamethasone ... See full document
46
Treatments for macular oedema following central retinal vein occlusion : systematic review
... Some anti-VEGF therapies, including bevacizumab, ranibizumab and a fl ibercept, have also been shown to be effective in short-term studies for the treatment of patients with macular oedema and CRVO. Bevacizumab has ... See full document
53
Impact of injection therapy on retinal patients with diabetic macular edema or retinal vein occlusion
... to participate. All willing respondents were sent a question- naire, which took ~ 20 minutes to complete. On some occa- sions, the respondents preferred to complete the interview on the telephone and the recruiter then ... See full document
5
Matched control study of visual outcomes after arteriovenous sheathotomy for branch retinal vein occlusion
... tories Inc., Fort Worth, Texas, USA) under local anesthesia. After removal of the posterior hyaloid membrane, the internal limiting membrane was removed at the macular area and at the site of arteriovenous ... See full document
10
<p>The effects of temporary intraocular pressure spikes after intravitreal dexamethasone implantation on the retinal nerve fiber layer</p>
... branch retinal vein occlusion (BRVO), central retinal vein occlusion (CRVO), DME, noninfectious posterior uveitis, wAMD, and CME with 48 and 21 patients meeting inclusion ... See full document
28
Intravitreal Bevacizumab with Grid Photocoagulation for Recurrent Macular Edema Secondary to Retinal Vein Occlusion
... of macular edema after grid pho- tocoagulation combined with intravitreal bevacizumab (IVB) for recurrent macular edema associated with ...eye due to macular edema ... See full document
12
Retinal vein occlusion: pathophysiology and treatment options
... Over recent years there has been great interest in the pote- ntial role of thrombophilia in the development of RVO and in particular CRVO. Thrombophilia refers to the propensity to develop thrombosis (usually venous) ... See full document
28
Clinical applications of the sustained-release dexamethasone implant for treatment of macular edema
... Macular edema is one of the leading causes of vision loss among patients with retinal vein occlusion, diabetic retinopathy, and posterior-segment inflammatory ...of macular ... See full document
15
The comparison of intravitreal triamcinolone and bevacizumab in patients with macular edema secondary to branch retinal vein occlusion
... IVTA was more effective than IVB in the early period, but no significant difference between groups was found at the final visit. IVTA induced significant retinal thinning compared to IVB in ischemic BRVO in the ... See full document
21
Grid photocoagulation combined with intravitreal bevacizumab for recurrent macular edema associated with retinal vein occlusion
... for macular edema associated with RVO that recurred after the previous ...showed macular edema with a loss of ...recurrent macular edema, each patient underwent an additional IVB ... See full document
6
Related subjects